The Collaborative Islet Transplantation Registry Program

by: Michael Saunders

The National Institutes of Health, more commonly referred to as NIH, is a federal government agency operating under the United States Department of Health and Human Services that's greatly accountable for financially supporting all of the nation's biomedical and health-related research studies.

The initiatives of the NIH are all specially designed to assist in the attainment of its primary agency mission which is "to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In accordance with this mission, the National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

The registry is comprised of substantial data regarding human islet transplantation experience from the year 1999 to present. The data also includes information concerning pancreas donors, islet preparations, transplantation procedures, associated therapies, and recipient outcomes.

The program in focus seeks to improve the availability and dissemination of these data to islet transplant centers, and the rest of the medical community.

  (continued...)

The Collaborative Islet Transplantation Registry Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Government Grants Within The United States Health Sector
The health care system in the US is as diverse as it is all-encompassing. A huge number of health care facilities are now owned by private sectors while a huge chunk of health insurance plans are primarily provided by the government in the public sector.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---